BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29172053)

  • 1. Associations of neurofunctional, morphometric and metabolic abnormalities with clinical symptom severity and recognition deficit in obsessive-compulsive disorder.
    Moon CM; Jeong GW
    J Affect Disord; 2018 Feb; 227():603-612. PubMed ID: 29172053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain morphological alterations and cellular metabolic changes in patients with generalized anxiety disorder: A combined DARTEL-based VBM and (1)H-MRS study.
    Moon CM; Jeong GW
    Magn Reson Imaging; 2016 May; 34(4):429-36. PubMed ID: 26708039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Working memory dysfunction associated with brain functional deficits and cellular metabolic changes in patients with generalized anxiety disorder.
    Moon CM; Sundaram T; Choi NG; Jeong GW
    Psychiatry Res Neuroimaging; 2016 Aug; 254():137-44. PubMed ID: 27442922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy.
    Park SE; Choi NG; Jeong GW
    Acta Neuropsychiatr; 2017 Jun; 29(3):164-169. PubMed ID: 27748207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral white matter volume changes in patients with obsessive-compulsive disorder: Voxel-based morphometry.
    Park SE; Jeong GW
    Psychiatry Clin Neurosci; 2015 Nov; 69(11):717-23. PubMed ID: 25966931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
    Starck G; Ljungberg M; Nilsson M; Jönsson L; Lundberg S; Ivarsson T; Ribbelin S; Ekholm S; Carlsson A; Forssell-Aronsson E; Carlsson ML
    J Neural Transm (Vienna); 2008 Jul; 115(7):1051-62. PubMed ID: 18528631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic change in the right dorsolateral prefrontal cortex and its correlation with symptom severity in patients with generalized anxiety disorder: Proton magnetic resonance spectroscopy at 3 Tesla.
    Moon CM; Kang HK; Jeong GW
    Psychiatry Clin Neurosci; 2015 Jul; 69(7):422-30. PubMed ID: 25611853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
    Zhu Y; Fan Q; Han X; Zhang H; Chen J; Wang Z; Zhang Z; Tan L; Xiao Z; Tong S; Maletic-Savatic M; Li Y
    J Affect Disord; 2015 Jun; 178():193-200. PubMed ID: 25819113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.
    Jang JH; Kwon JS; Jang DP; Moon WJ; Lee JM; Ha TH; Chung EC; Kim IY; Kim SI
    Am J Psychiatry; 2006 Jul; 163(7):1202-7. PubMed ID: 16816225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate.
    Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Taravari V
    Psychiatry Res; 2014 Dec; 224(3):275-80. PubMed ID: 25241042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter structural alterations in pediatric obsessive-compulsive disorder: relation to symptom dimensions.
    Lázaro L; Ortiz AG; Calvo A; Ortiz AE; Moreno E; Morer A; Calvo R; Bargallo N
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():249-58. PubMed ID: 24977330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
    Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using proton magnetic resonance spectroscopy: a controlled study.
    Kosová E; Pajuelo D; Fajnerová I; Greguš D; Brunovský M; Stopková P; Škoch A; Fürstová P; Španiel F; Horáček J
    BMC Psychiatry; 2023 Oct; 23(1):734. PubMed ID: 37817131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing brain magnetic resonance spectroscopy findings of pediatric treatment-naive obsessive-compulsive disorder patients with healthy controls.
    Yalçın O; Sener S; Konuş Boyunağa OL; Sarıpınar EG; Oğur T; Güney E; Akın Sarı B; Işeri E
    Turk Psikiyatri Derg; 2011; 22(4):222-9. PubMed ID: 22143947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems.
    van den Heuvel OA; Remijnse PL; Mataix-Cols D; Vrenken H; Groenewegen HJ; Uylings HB; van Balkom AJ; Veltman DJ
    Brain; 2009 Apr; 132(Pt 4):853-68. PubMed ID: 18952675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
    Chen Y; Meng Z; Zhang Z; Zhu Y; Gao R; Cao X; Tan L; Wang Z; Zhang H; Li Y; Fan Q
    Aust N Z J Psychiatry; 2019 Mar; 53(3):207-218. PubMed ID: 30354192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
    Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
    Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between oxidative stress markers and 1H-Magnetic resonance spectroscopy findings in obsessive compulsive disorder.
    Subaşı Turgut F; Bulut M; Hattapoğlu S; Güneş M; Cemal Kaya M; Ekici F; Guli Çetinçakmak M; Kaplan İ; Atmaca M
    Brain Res; 2024 Jun; 1833():148852. PubMed ID: 38494099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.